Joseph EdelmanTVTX history

Issuer:
TRAVERE THERAPEUTICS INC
Quarters tracked:
18 (Q4 2020Q1 2026)
Current shares:
4,142,551
Current value:
$123.08M
Peak shares:
4,278,180 (Q4 2025)
Overall change:
+19%
QuarterSharesValue$/ShareShare ΔΔ%
Q1 20264,142,551$123.08M$29.71-135,629-3%
Q4 20254,278,180$163.47M$38.21+483,565+13%
Q3 20253,794,615$90.69M$23.90+2,960,363+355%
Q2 2025834,252$12.35M$14.80+834,252+100%
Q1 2024SOLD-400,000-100%
Q4 2023400,000$3.60M$8.9900%
Q3 2023400,000$3.58M$8.94+309,252+341%
Q2 202390,748$1.39M$15.3600%
Q1 202390,748$2.04M$22.4900%
Q4 202290,748$1.91M$21.0300%
Q3 202290,748$2.24M$24.64-479,336-84%
Q2 2022570,084$13.81M$24.23-1,275,471-69%
Q1 20221,845,555$47.56M$25.7700%
Q4 20211,845,555$57.29M$31.04-120,000-6%
Q3 20211,965,555$47.66M$24.25+120,000+7%
Q2 20211,845,555$26.93M$14.59-1,452,864-44%
Q1 20213,298,419$82.36M$24.97-195,188-6%
Q4 20203,493,607$95.22M$27.25NEW